.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Clinicians must now thoroughly cross-check medications against the World Anti-Doping Agency (WADA) prohibited list. Many common items like cough syrups or steroids contain banned ingredients. Thus, a simple error can lead to severe penalties for an athlete. However, you can manage these risks through better awareness. Instead of assuming safety, verify every pharmaceutical product before prescribing. Furthermore, you should educate athletes about the dangers of online supplements.
If a banned substance is necessary for health, you must document the clinical need meticulously. Moreover, the athlete must apply for a Therapeutic Use Exemption (TUE) immediately. This process ensures that the treatment is legally recognized by sports authorities. Additionally, the NMC is integrating these concepts into the undergraduate medical curriculum. This shift will prepare future doctors for sports-specific medical challenges. Consequently, the medical community will act as a primary shield against accidental doping.
Q1: What should a doctor do if an athlete requires a banned medication?
The practitioner must document the medical necessity and help the athlete file for a Therapeutic Use Exemption (TUE) before starting treatment.
Q2: How does the NMC plan to increase anti-doping awareness?
The NMC intends to incorporate basic anti-doping training into the MBBS curriculum and continuing professional development programs for existing doctors.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The NMC has issued new anti-doping guidelines for doctors to prevent accidental doping in athletes through responsible prescription and supplement monitorin...
6 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
